9Maciejewski JP,Selleri C, Sato T, et al. Increased expression of Fas antigen on bone marrow CD34^+ cells of patients with aplastic [J]. Br, J Haematol,1995;91(1):245-252
10Nakao S. Immune mechanism of aplastic anemia. Int J Hematol[M],1997, 66:127-134
1Nitsche A,Junghahn I,Thulke S,et al.Interleukin-3 promotes proliferation and differentiation of human hematopoietic stem cells but reduces their repopulation potential in NOD/SCID mice[J].Stem Cells,2003,21(2):236-244.
2Arcasoy MO,Amin K,Vollmer RT,et al.Erythropoietin and erythropoietin receptor expression in human prostate cancer[J].Mod Pathol,2005,18(3):421-430.
3Yamazaki H,Sugimori C,Chuhjo T,et al.Cyclosporine therapy for acquired aplastic anemia:predictive factors for the response and long-term prognosis[J].Int J Hematol,2007,85(3):186-190.
4Wada Y,Lu R,Zhou D,et al.Selective abrogation of Th1 response by STA-5326,a potent IL-12/IL-23 inhibitor[J].Blood,2007,109(3):1156-1164.
5Scheinberg P,Nunez O,Young NS.Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia[J].Br J Haematol,2006,133(6):622-627.
6Hattori M,Terasawa T,Tsushita K,et al.The status of antithymocyte globulin therapy for adult patients in Japan:retrospective analysis of a nationwide survey[J].Int J Hematol,2008,87(1):48-55.
